Chenghao Lu

No. 13, Liulin Road
Dayingmen, 300222, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Altered right amygdala-prefrontal connectivity is associated with symptom severity in major depressive disorder: An exploratory analysis of anxiety subgroups.

Altered right amygdala-prefrontal connectivity is associated with symptom severity in major depressive disorder: An exploratory analysis of anxiety subgroups.

Journal: Neuroscience letters

Published: June 08, 2026

Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia.

Untargeted plasma metabolomics identifies metabolite signatures associated with suicidality status in chronic schizophrenia.

Journal: European archives of psychiatry and clinical neuroscience

Published: May 20, 2026

Impact of severe anxiety, depression, and their comorbidity on glucose metabolism in first-episode antipsychotic-naïve schizophrenia patients.

Impact of severe anxiety, depression, and their comorbidity on glucose metabolism in first-episode antipsychotic-naïve schizophrenia patients.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: February 25, 2026

Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive function.

Static and dynamic alterations of local brain activity in schizophrenia and associations with clinical symptoms and cognitive function.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: February 15, 2026

Sex-specific associations between serum uric acid, psychopathology, and cognition in deficit schizophrenia.

Sex-specific associations between serum uric acid, psychopathology, and cognition in deficit schizophrenia.

Journal: Schizophrenia research

Published: February 05, 2026

Cognitive function differences across subtypes of first-episode antipsychotic-naïve schizophrenia: insights from event-related potentials.

Cognitive function differences across subtypes of first-episode antipsychotic-naïve schizophrenia: insights from event-related potentials.

Journal: European archives of psychiatry and clinical neuroscience

Published: December 02, 2025

Elevated prolactin and association with treatment resistance indicators in first-hospitalized schizophrenia spectrum disorders: a real-world cohort study.

Elevated prolactin and association with treatment resistance indicators in first-hospitalized schizophrenia spectrum disorders: a real-world cohort study.

Journal: BMC psychiatry

Published: November 06, 2025

Atherosclerosis risk and clinical correlates in first-episode drug-naïve patients with major depressive disorder: a large-scale cross-sectional study.

Atherosclerosis risk and clinical correlates in first-episode drug-naïve patients with major depressive disorder: a large-scale cross-sectional study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: August 29, 2025

Suicide risk, psychopathology and cognitive impairments in schizophrenia with insomnia: a large-scale cross-sectional study.

Suicide risk, psychopathology and cognitive impairments in schizophrenia with insomnia: a large-scale cross-sectional study.

Journal: BMC psychiatry

Published: July 04, 2025

Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning.

Metabolic biomarkers of treatment-resistant schizophrenia and cognitive correlates: insights from a machine learning.

Journal: Molecular psychiatry

Published: May 23, 2025

Body mass index-specific metabolic profiles in schizophrenia: implications for cognitive dysfunction and psychopathology.

Body mass index-specific metabolic profiles in schizophrenia: implications for cognitive dysfunction and psychopathology.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: March 02, 2025

Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia.

Plasma Metabolic Characteristics and Potential Biomarker Combinations in Schizophrenia Patients With Tardive Dyskinesia.

Journal: Schizophrenia bulletin

Published: February 21, 2025

Showing 1-12 of 25

Last Updated: 09/26/2026